相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy
Cristina E. Tognon et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Targeting the Insulin Growth Factor Receptor 1
Fernanda I. Arnaldez et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2012)
Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cell
Neetu Kalra et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Human Monoclonal Antibodies Targeting Nonoverlapping Epitopes on Insulin-like Growth Factor II as a Novel Type of Candidate Cancer Therapeutics
Weizao Chen et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Receptor Tyrosine Kinases and Targeted Cancer Therapeutics
Kenji Takeuchi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer
Rulla M. Tamimi et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Prognostic associations of insulin-like growth factor-1 receptor in primary uveal melanoma
Rana'a T. Al-Jamal et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2011)
Targeting the insulin-like growth factor network in cancer therapy
Isabel Heidegger et al.
CANCER BIOLOGY & THERAPY (2011)
Gene Expression Profiling in Multiple Myeloma-Reporting of Entities, Risk, and Targets in Clinical Routine
Tobias Meissner et al.
CLINICAL CANCER RESEARCH (2011)
Enhanced Efficacy of IGF1R Inhibition in Pediatric Glioblastoma by Combinatorial Targeting of PDGFRα/β
Aleksandra Bielen et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Expression of IGF-1R in Colorectal Polyps and its Role in Colorectal Carcinogenesis
H-B. Shan et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2011)
The Insulin-like Growth Factor Signaling Pathway as a Target for Treatment of Colorectal Carcinoma
Gideon P. Ewing et al.
CLINICAL COLORECTAL CANCER (2010)
Structural Basis of Human p70 Ribosomal S6 Kinase-1 Regulation by Activation Loop Phosphorylation
Tomoko Sunami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis
Sebastio Perrini et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma
Shucheng Yin et al.
NEURO-ONCOLOGY (2010)
Sex Steroids Upregulate the IGF-1R in Prostate Cancer Cells through a Nongenotropic Pathway
Giuseppe Pandini et al.
STEROID ENZYMES AND CANCER (2009)
Cardiac insulin-like growth factor-1 and cyclins gene expression in canine models of ischemic or overpacing cardiomyopathy
Maryam Mahmoudabady et al.
BMC CARDIOVASCULAR DISORDERS (2009)
Differential Roles of Insulin-like Growth Factor Receptor- and Insulin Receptor-mediated Signaling in the Phenotypes of Hepatocellular Carcinoma Cells
Ya-Wen Chen et al.
NEOPLASIA (2009)
Insulin, insulin-like growth factors and neoplasia
Michael Pollak
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells
Patricia Maiso et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Insulin-Like Growth Factor Binding Protein-2 Is a Novel Therapeutic Target Associated with Breast Cancer
Alan I. So et al.
CLINICAL CANCER RESEARCH (2008)
Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis
Christian Moser et al.
EUROPEAN JOURNAL OF CANCER (2008)
IGF Binding Proteins (IGFBPs) and Regulation of Breast Cancer Biology
Claire M. Perks et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
Insulin-like growth factor-I receptor acts as a growth regulator in synovial sarcoma
N. Friedrichs et al.
JOURNAL OF PATHOLOGY (2008)
Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials
Jordi Rodon et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Insulin-like growth factor-I receptor blockade by a specific tyrosine kinase inhibitor for human gastrointestinal carcinomas
Wenhua Piao et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors
Chi Tarn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor
Lisbeth Gauguin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer
Joanna Lisztwan et al.
BREAST CANCER RESEARCH (2008)
A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor-dependent tumor growth in vivo
Qun-Sheng Ji et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma
Mark G. Slomiany et al.
CANCER LETTERS (2007)
Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K-Akt pathway activation in glioblastoma and prostate cancer
R. Mehrian-Shai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function
Palle G. Laustsen et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Preclinical in vivo study of new insulin-like growth factor-1 receptor -: Specific inhibitor in Ewing's sarcoma
Maria C. Manara et al.
CLINICAL CANCER RESEARCH (2007)
The role of the IGF system in cancer growth and metastasis: Overview and recent insights
Amir Abbas Samani et al.
ENDOCRINE REVIEWS (2007)
The role of insulin receptor isoforms and hybrid Insulin/IGF-I receptors in human cancer
Antonino Belfiore
CURRENT PHARMACEUTICAL DESIGN (2007)
Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo
Barbara Tanno et al.
CLINICAL CANCER RESEARCH (2006)
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity
Estela Jacinto et al.
CELL (2006)
Effects of insulin-like growth factor-1 receptor inhibition in mesothelioma
Bryan A. Whitson et al.
ANNALS OF THORACIC SURGERY (2006)
Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins
Tomasz Sitar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2-overexpressing breast tumors and potentiates Herceptin activity in vivo
Lori Jerome et al.
CANCER RESEARCH (2006)
Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II
Eva S. Schemhammer et al.
ENDOCRINE-RELATED CANCER (2006)
Blockade of IGF-1 receptor tyrosine kinase has antlineoplastic effects in hepatocellular carcinoma cells
M Höpfner et al.
BIOCHEMICAL PHARMACOLOGY (2006)
The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours
M Höpfner et al.
ENDOCRINE-RELATED CANCER (2006)
Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: Implications for anti-insulin-like growth factor therapy in breast cancer
D Sachdev et al.
CANCER RESEARCH (2006)
The insulin-like growth factor system and its pleiotropic functions in brain
VC Russo et al.
ENDOCRINE REVIEWS (2005)
Role of tyrosine kinase inhibitors in cancer therapy
A Arora et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2
RJ Levitt et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Blocking insulin-like growth factor-I receptor as a strategy for targeting cancer
F Hofmann et al.
DRUG DISCOVERY TODAY (2005)
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors
K Scotlandi et al.
CANCER RESEARCH (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Activating p38 MAPK - New tricks for an old kinase
PR Mittelstadt et al.
CELL CYCLE (2005)
In vivo antitumor activity of NVP-AEW541 -: A novel, potent, and selective inhibitor of the IGF-IR kinase
C García-Echeverría et al.
CANCER CELL (2004)
A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells
D Sachdev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Ets ternary complex transcription factors
G Buchwalter et al.
GENE (2004)
Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors
M Goya et al.
CANCER RESEARCH (2004)
The genetics of human longevity
WS Browner et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth
A Girnita et al.
CANCER RESEARCH (2004)
The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway
D Vasilcanu et al.
ONCOGENE (2004)
The igf-1 receptor in cancer biology
R Baserga et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Increased expression of the mannose 6-phosphate Insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo
JS Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
The complex biology of the receptor for the insulin-like growth factor-1
G Romano
DRUG NEWS & PERSPECTIVES (2003)
Structure of apo, unactivated insulin-like growth factor-1 receptor kinase at 1.5 Å resolution
S Munshi et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2003)
Cellular actions of the insulin-like growth factor binding proteins
SM Firth et al.
ENDOCRINE REVIEWS (2002)
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved
G Pandini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer
N Reinmuth et al.
LABORATORY INVESTIGATION (2002)
Control of cell survival by IGF signaling pathways
AM Vincent et al.
GROWTH HORMONE & IGF RESEARCH (2002)
Insulin-like growth factors and cancer
G Fürstenberger et al.
LANCET ONCOLOGY (2002)
Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-IR) are mediated by an induction of IGF-IR promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2
PN Nair et al.
ONCOGENE (2001)
Distinct and overlapping functions of insulin and IGF-I receptors
J Nakae et al.
ENDOCRINE REVIEWS (2001)
Structure and autoregulation of the insulin-like growth factor 1 receptor kinase
S Favelyukis et al.
NATURE STRUCTURAL BIOLOGY (2001)
IGF-I receptor signalling in transformation and differentiation
B Valentinis et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)
Structure and function of the type 1 insulin-like growth factor receptor
TE Adams et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2000)
分享论文
